Pierre Foidart, Medical Oncologist, Head of Clinic at CHU de Liège, shared a post by Kornelia Polyak, Professor of Medicine At Dana-Farber Cancer Institute on LinkedIn, adding:
“Very happy to see the work of Marie-Anne Goyette published in Cancer Discovery! It was a real pleasure to contribute to this story with really high clinical relevance!
March 26 was an incredible month for Kornelia Polyak lab with three papers accepted. Can’t wait to see the next 2 online!”
Quoting Kornelia Polyak’s post:
“And the first of our three recent papers is online.
It’s a cool and clinically very important story. Patients with HER2 heterogeneous tumors need different – better- treatment strategies.”
Title: HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapies
Authors: Marie-Anne Goyette, Christopher Graser, Marco Seehawer, Andriana Patmanidis, Ernesto Rojas Jimenez, Avni Kamat, Pengze Yan, Anne Fassl, Pierre Foidart, Zheqi Li, Ameera James, George Sflomos, Cathrin Brisken, Piotr Sicinski, Franziska Michor, Kornelia Polyak
Other Articles Featuring Pierre Foidart and Kornelia Polyak on OncoDaily.